Organisation & Governance 

AiBST is a hybrid institute with elements of tertiary academic institutions and  biomedical R&D companies to enable it to operate in an environment which still requires capacity and capability building with respect to skilled manpower and research infrastructure, at the same time be translational research oriented to deliver on medical products and services that address Africa’s healthcare challenges. Our ultimate aim is to deliver life transforming healthcare solutions.

 

Organisation

Organisation

Governance

The governance bodies of the African Institute of Biomedical Science and technology (AiBST) comprise the Board of Directors (BD), the Academic and the R&D Committee (ARDC), the International Advisory Board (IAB) and the Management Committee (MC).  The BD is composed of the directors under whom the institute is registered. The BD meets once a month. The ARDC is composed of all Professors , Directors and Associate Directors at AiBST. The ARDC meets 4 times a year to discuss and make recommendations for AiBST’s research focus in response to medical needs and international standards. The IAB is composed of experts of international standing in diverse fields of expertise of importance to the strategic development of AiBST. The IAB meets once a year at AiBST but has at least 4 teleconferences a year. The MC is composed of the President and Chief Scientific Officer, the Managing Director of Administration & Finance, The Directors of Molecular Sciences and  Medical Bioanalytics. The MC is responsible for the overall management of AiBST and it meets once a week. The whole governing body meat once a year at the Annual General Meeting (AGM) where major changes (Change of Board members,  and appointments (Manager and Associated Director level appointments upwards) are made or officially endorsed as stipulated in the institute’s constitution.

 

Current President and Chief Scientific Officer

Prof. Collen Masimirembwa (DPhil, PhD)

 Prof. Collen Masimirembwa (DPhil, PhD)